‘1 Strong and 2 Medium’ positions in Celebrex generic market

In the market of ‘Celebrex(generic name: celecoxib), a selective COX-2 inhibitor anti-inflammatory drug, which was recognized as the most competitive market due to approximately 100 generic products launched, Chong Kun Dang has acquired a prior advantage.

In addition, ‘Celebrex’ of Pfizer Korea, the original company, had to be satisfied with KRW 10 billion quarterly prescriptions due to the dr...